According to one of the conditions, as post marketing surveillance the companies will have to submit periodic safety update reports to the drug regulator.
from Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/3ezIX4v
Home »
Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com
» Molnupiravir authorisation comes with a condition - further trials in the next three months
https://ift.tt/eA8V8J
No comments:
Post a Comment